|
Apr 27
|
Baudax Bio Announces Pricing of $4 Million Public Offering
|
|
Apr 25
|
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
|
|
Apr 24
|
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
|